Webb17 sep. 2024 · Description: The goal of the trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis. Study Design Patients were randomized in 1:1 fashion to either CEP (n = 1,501) or control (n = 1,499). Webb心闻周刊丨protected tavr研究:脑保护装置的是与非——李捷教授解析如何降低tavr围术期卒中风险 本期《心闻周刊》为大家带来心血管领域6条最新研究和6条行业动态,同时特别邀请到 广东省人民医院李捷教授 对PROTECTED TAVR研究进行深入解读与探讨。
心闻周刊丨PROTECTED TAVR研究:脑保护装置的是与非——李捷 …
Webb22 sep. 2024 · PROTECTED TAVR investigators enrolled 3,000 patients at 51 centers in North America, Europe and Australia between February 2024 and January 2024. Patients were randomized to receive TAVR with (n = 1,501) or without (n = 1,499) the Sentinel CEP device. All patients underwent neurological examination before and after the procedure. Webb29 jan. 2024 · Transcatheter aortic-valve replacement (TAVR) is an alternative to surgery in patients with symptomatic aortic stenosis, on the basis of clinical evidence from … providence promotional hastings
PROTECTED TAVR Study - Boston Scientific
WebbPROTECTED TAVR研究纳入了51个中心的3000例接受TAVR治疗的患者,随机分配至脑保护装置组和对照组。 结果显示两组在主要终点发生率方面无统计学差异, 脑保护装置未能降低TAVR后整体卒中风险。 但进一步分析显示,脑保护装置组致残性卒中发生率更低 【4】 。 而目前脑保护装置在我国尚属于应用起始阶段,需要更多的临床实践来积累经验。 WebbSafeguard quality of life for Transcatheter Aortic Valve Replacement (TAVR) patients in just four minutes 2 per procedure. New data from the PROTECTED TAVR Study showed … Webb18 sep. 2024 · The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement Reported from TCT 2024 Jonathan Curio … providence primary care physicians missoula